-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LBfkX1677Yk77JEnrb+3CYRpFZoMAG/XKZMq62I4OaYOFR9VZx7Id60FAStnEMb1 YVMCDq3ttyWbIMr9Iszd+A== 0001034447-05-000002.txt : 20050601 0001034447-05-000002.hdr.sgml : 20050601 20050601194225 ACCESSION NUMBER: 0001034447-05-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050527 FILED AS OF DATE: 20050601 DATE AS OF CHANGE: 20050601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VISX INC CENTRAL INDEX KEY: 0000837991 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 061161793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3400 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: 4087332020 MAIL ADDRESS: STREET 1: VISX INC STREET 2: 3400 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051-0703 FORMER COMPANY: FORMER CONFORMED NAME: TAUNTON TECHNOLOGIES INC DATE OF NAME CHANGE: 19901212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEBUONO LAUREEN CENTRAL INDEX KEY: 0001034447 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10694 FILM NUMBER: 05871901 BUSINESS ADDRESS: STREET 1: 3400 CENTRAL EXPRESSWAY CITY: SANTA CLARA STATE: CA ZIP: 95051 BUSINESS PHONE: 4087332020 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-05-27 1 0000837991 VISX INC EYE 0001034447 DEBUONO LAUREEN 3400 CENTRAL EXPRESSWAY SANTA CLARA CA 95051 1 0 0 0 Stock Option (Right to Buy) 9.60 2005-05-27 4 D 0 40000 D 2013-03-17 Common Stock 40000 0 D Phantom Stock (Right to Aquire) 2005-05-27 4 D 0 880 D Common Stock 880 0 D Stock Option (Right to Buy) 22.84 2005-05-27 4 D 0 10000 D 2014-05-13 Common Stock 10000 0 D Phantom Stock (Right to Aquire) 2005-05-27 4 D 0 657 D Common Stock 657 0 D This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of March 17, 2003, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 25,690 shares of Advanced Medical Optics, Inc. common stock for $14.95 per share. The phantom stock was credited to the Reporting Person's account under the 1995 Director Option and Stock Deferral Plan and upon exercise will be settled in common stock on a 1-for-1 basis. This right, which becomes payable in common stock following the Reporting Person's termination of service as a director, in accordance with the deferral election made by the Reporting Person pursuant to the 1995 Director Option and Stock Deferral Plan, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with 565 shares of Advanced Medical Optics, Inc. common stock for $26.58 per share. This option, which provided for vesting at 25% of the shares subject to the option vest upon the first anniversary of the grant and 1/48 of the shares subject to the option vest at the end of each full month for 36 months following the initial grant date of May 13, 2004, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with an option to purchase 6,422 shares of Advanced Medical Optics, Inc. common stock for $35.57 per share. This right, which becomes payable in common stock following the Reporting Person's termination of service as a director, in accordance with the deferral election made by the Reporting Person pursuant to the 1995 Director Option and Stock Deferral Plan, was assumed by Advanced Medical Optics, Inc. in the merger and replaced with 421 shares of Advanced Medical Optics, Inc. common stock for $35.65 per share. Laureen De Buono 2005-06-01 -----END PRIVACY-ENHANCED MESSAGE-----